Home

GENERAL ATLANTIC GENPAR (BERMUDA), L.P.

CIK 1467927 · last filed 2026-06-09

GENERAL ATLANTIC GENPAR (BERMUDA), L.P. is a corporate insider who has filed 12 SEC Form 4 insider transactions across 5 companies since 2021. The most recent filing shows the insider bought $300.0M of LFTO on Jun 9, 2026. Across all open-market trades the lifetime net is −$1.35B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.06B across reported positions. The firm reports its address in New York, NY. 40 SEC filings were submitted jointly with GAP (Bermuda) L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.06B

Companies

5

Total Filings

12

Lifetime Open-Market Net

-$1.35B

Filer Profile

Reported Address
C/O GENERAL ATLANTIC SERVICE COMPANY,LLC
55 EAST 52ND ST. 32ND FLOOR
NEW YORK, NY 10055
Phone
(212) 715-4000
State of Incorporation
DE
Related Filers
GAP (Bermuda) L.P. — 40 joint filings, latest 2026-06-09
General Atlantic (SPV) GP, LLC — 29 joint filings, latest 2026-06-09
GAP Coinvestments CDA, L.P. — 21 joint filings, latest 2026-06-09
General Atlantic (SPV) GP (Bermuda), LLC — 12 joint filings, latest 2026-05-14
Atlantic GenPar (Lux) SCSp General — 10 joint filings, latest 2023-06-26
General Atlantic Partners (Bermuda) IV, L.P. — 10 joint filings, latest 2026-05-14
GAP COINVESTMENTS III, LLC — 9 joint filings, latest 2026-06-09
GAP COINVESTMENTS IV, LLC — 9 joint filings, latest 2026-06-09
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LFTO Director 25,315,646 $18.35 $464.54M $300.00M 1 2026-06-09
ALKT Director 15,379,451 $20.51 $315.43M $12.17M 4 2026-03-16
YOU 10%+ Owner 6,662,472 $42.23 $281.36M -$1.73B 2 2023-01-30
HireRight Holdings Corp (HRT) Delisted Director 32,109,898 $14.36 $461.10M $51.58M 4 2022-12-12
CinCor Pharma, Inc. (CINC) Delisted 10%+ Owner 4,209,470 $29.06 $122.33M $12.45M 1 2022-08-15

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-09 LFTO Buy (P) +13,043,470 $300.00M EDGAR
2026-03-16 ALKT Buy (P) +4,500,000 $82.48M EDGAR
2024-11-12 ALKT Sell (S) −1,875,000 -$70.31M EDGAR
2023-01-30 YOU Mixed −10,766,940 -$522.39M EDGAR
2022-12-12 HireRight Holdings Corp (HRT) Delisted Buy (P) +143,472 $1.77M EDGAR
2022-11-29 HireRight Holdings Corp (HRT) Delisted Buy (P) +2,367,296 $28.05M EDGAR
2022-11-23 HireRight Holdings Corp (HRT) Delisted Buy (P) +1,040,216 $11.05M EDGAR
2022-11-18 HireRight Holdings Corp (HRT) Delisted Buy (P) +1,109,976 $10.70M EDGAR
2022-08-15 CinCor Pharma, Inc. (CINC) Delisted Buy (P) +415,000 $12.45M EDGAR
2022-05-19 YOU Mixed −22,713,140 -$1.20B EDGAR
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.